November 2022
1. CARTWRIGHT M, Toit RL, Africander D
   The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
   Biochem Biophys Res Commun. 2022;639:70-76.
   

   >> Share

   
   
2. OMAR IS, Mat Adenan NA, Godoy A, Teo IH, et al
   Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium.
   Biochem Biophys Res Commun. 2022;628:133-140.
   

   >> Share

   
   November 2021
3. DAS A, Bysack A, Raghuraman H
   Effectiveness of dual-detergent strategy using Triton X-100 in membrane protein purification.
   Biochem Biophys Res Commun. 2021;578:122-128.
   

   >> Share

   
   April 2021
4. DING F, Qiu C, Li W, Liu Z, et al
   CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
   Biochem Biophys Res Commun. 2021;548:148-154.
   

   >> Share

   
   December 2020
5. ENFIELD K, Dlamini S, Avenant C, Kuipa M, et al
   Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens.
   Biochem Biophys Res Commun. 2020;533:1027-1033.
   

   >> Share

   
   September 2020
6. ENFIELD K, Cartwright M, Toit RL, Avenant C, et al
   Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.
   Biochem Biophys Res Commun. 2020 Sep 29. pii: S0006-291X(20)31799.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share